Of the 25 biomarkers evaluated, only GM-CSF, SCGF-β, SCF, NGF-β and RANTES were below the level of detection, preventing us from fully assessing the chemokine and growth factor profile in the saliva of stroke patients. This evidence concerns the gene CCL5 and stroke disorder.